RENAISSANCE TECHNOLOGIES LLC - 29 Sep 2025 SCHEDULE 13G Report for Entero Therapeutics, Inc. Common stock, par value $0.0001 per share (ENTO)

Filing Manager: RENAISSANCE TECHNOLOGIES LLC
Reporting Manager: Renaissance Technologies LLC
Security: Entero Therapeutics, Inc. Common stock, par value $0.0001 per share
Symbol: ENTO
Shares outstanding: 1,588,235 shares
Disclosed Ownership: 86,400 shares
Ownership: 5.4%
Form type: SCHEDULE 13G
Filing time: 13 Nov 2025, 14:27:37 UTC
Date of event: 29 Sep 2025
Next filing: 12 Feb 2026
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Renaissance Technologies LLC	5.4%	86,400	86,400	0	Brian Felczak	Chief Financial Officer
Renaissance Technologies Holdings Corporation	5.4%	86,400	86,400	0	Brian Felczak	Vice President